These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10023511

  • 21. Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR).
    Devesa J, Lima L, Lois N, Fraga C, Lechuga MJ, Arce V, Tresguerres JA.
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):367-77. PubMed ID: 2574645
    [Abstract] [Full Text] [Related]

  • 22. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
    Grottoli S, Procopio M, Maccario M, Zini M, Oleandri SE, Tassone F, Valcavi R, Ghigo E.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
    [Abstract] [Full Text] [Related]

  • 23. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F, Benso A, Gottero C, Vito LD, Aimaretti G, Fubini A, Arvat E, Bobbio M, Ghigo E.
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [Abstract] [Full Text] [Related]

  • 24. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E, Di Vito L, Ramunni J, Gianotti L, Giordano R, Deghenghi R, Camanni F, Ghigo E.
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [Abstract] [Full Text] [Related]

  • 25. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [Abstract] [Full Text] [Related]

  • 26. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
    Gianotti L, Pincelli AI, Scacchi M, Rolla M, Bellitti D, Arvat E, Lanfranco F, Torsello A, Ghigo E, Cavagnini F, Müller EE.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
    [Abstract] [Full Text] [Related]

  • 27. Regulation of hypothalamic somatostatin by glucocorticoids.
    Devesa J, Barros MG, Gondar M, Tresguerres JA, Arce V.
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):277-82. PubMed ID: 7626468
    [Abstract] [Full Text] [Related]

  • 28. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG, Macfarlane P, Levitt NS, Millar RP.
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [Abstract] [Full Text] [Related]

  • 29. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

  • 30. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
    [Abstract] [Full Text] [Related]

  • 31. Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone.
    Arce VM, Cella SG, Locatelli V, Müller EE.
    Neuroendocrinology; 1991 May; 53(5):467-72. PubMed ID: 1908062
    [Abstract] [Full Text] [Related]

  • 32. Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa.
    Fassino S, Lanfranco F, Abbate Daga G, Mondelli V, Destefanis S, Rovera GG, Camanni F, Ghigo E, Arvat E, Gianotti L.
    J Endocrinol Invest; 2003 Jun; 26(6):503-7. PubMed ID: 12952362
    [Abstract] [Full Text] [Related]

  • 33. Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders.
    Rolla M, Andreoni A, Bellitti D, Ferdeghini M, Ghigo E, Müller EE.
    J Endocrinol; 1994 Feb; 140(2):327-32. PubMed ID: 8169565
    [Abstract] [Full Text] [Related]

  • 34. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB.
    J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
    [Abstract] [Full Text] [Related]

  • 35. Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa.
    Støving RK, Andersen M, Flyvbjerg A, Frystyk J, Hangaard J, Vinten J, Koldkjaer OG, Hagen C.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):391-6. PubMed ID: 11940052
    [Abstract] [Full Text] [Related]

  • 36. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
    Achermann JC, Hindmarsh PC, Robinson IC, Matthews DR, Brook CG.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518
    [Abstract] [Full Text] [Related]

  • 37. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
    Bellone J, Aimaretti G, Valetto MR, Bellone S, Baffoni C, Arvat E, Seminara S, Camanni F, Ghigo E.
    Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
    [Abstract] [Full Text] [Related]

  • 38. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E.
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [Abstract] [Full Text] [Related]

  • 39. GH/IGF-I axis in anorexia nervosa.
    Gianotti L, Lanfranco F, Ramunni J, Destefanis S, Ghigo E, Arvat E.
    Eat Weight Disord; 2002 Jun; 7(2):94-105. PubMed ID: 17644863
    [Abstract] [Full Text] [Related]

  • 40. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R, Gracia-Navarro F, Elsaesser F.
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.